September 28, 2026
All News
September 28, 2026
NRG Oncology Trial Results Show No Survival Benefit with the Use of Proton Therapy for Patients with Advanced Hepatocellular Carcinoma
Read MoreSeptember 27, 2026
Shortened Radiation Schedule Provides Similar Cancer Control and Patient-Reported Outcomes to Standard Radiation Following Surgery for High-Risk Prostate Cancer in NRG Oncology Trial
Read MoreSeptember 27, 2026
NRG Oncology SPPORT Analysis Highlights Potential Role of Genetic Testing in Identifying Prostate Cancer Patients Who May Benefit Most from Hormone Therapy
Read MoreSeptember 15, 2026
Several NRG Oncology Prostate Cancer Trials Reached Their Accrual Goals
Read MoreAugust 25, 2026
NRG Oncology Trial Results Show Favorable Bowel Health Related Quality of Life Outcomes for Localized Immediate Risk Prostate Cancer Treated with Stereotactic Body Radiation Therapy – Results Published
Read MoreAugust 25, 2026
Patient-Reported Outcome Analysis of NRG Oncology Trial in Limited-Stage Small Cell Lung Cancer Suggests More Favorable Quality-of-Life Trajectory with Twice-Daily versus Once-Daily Radiation – Results Published
Read MoreAugust 12, 2026
NRG Oncology Received a Perfect Grant Score and Increased Funding from the National Cancer Institute
Read MoreAugust 12, 2026
Advocate Angle: Participation Powers Research: Behind Every Milestone, a Story of Research
Read MoreAugust 12, 2026
NRG Oncology Awards 12 Fellows for the Early Career Mentored Fellowship Program
Read MoreAugust 11, 2026